Chapel Allerton Hospital is located in the area of Chapel Allerton, Leeds, West Yorkshire, England and is operated by the Leeds Teaching Hospitals NHS Trust. The main entrance is on Chapeltown Road, with vehicle exits onto Harehills Lane and Newton Road.

There are 132 beds in Chapel Allerton Hospital.

During the past decade, Chapel Allerton Hospital conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 11 clinical trials were completed, i.e. on average, 73.3% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 8 clinical trials were completed. i.e. 88.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chapel Allerton Hospital" #1 sponsor was "Amgen" with 5 trials, followed by "University of Leeds" with 5 trials sponsored, "LEO Pharma" with 3 trials sponsored, "ISDIN" with 2 trials sponsored and "Janssen Pharmaceutica N.V., Belgium" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chapel Allerton Hospital" #1 collaborator was "University of Oxford" with 3 trials as a collaborator, "Arthritis Research UK" with 2 trials as a collaborator, "Digna Biotech S.L." with 2 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Chapel Allerton Hospital" are "Psoriatic Arthritis" (5 trials), "Arthritis, Psoriatic" (3 trials), "Giant Cell Arteritis" (2 trials), "Knee Osteoarthritis" (2 trials) and "Psoriasis" (2 trials). Many other conditions were trialed in "Chapel Allerton Hospital" in a lesser frequency.

Most popular intervention types in "Chapel Allerton Hospital" are "Drug" (22 trials), "Biological" (2 trials), "Dietary Supplement" (2 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Apremilast" (2 trials), "Guselkumab" (2 trials), "Guselkumab 100 mg" (2 trials) and "Apremilast 20mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Chapel Allerton Hospital" are 30 trials for "All" genders.

Currently, there are NaN active trials in "Chapel Allerton Hospital". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Chapel Allerton Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Chapel Allerton Hospital, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 1 trials that are defined as “Not Applicable".